ArticleTherapeutic advances in medical oncology2025

Efficacy of sacituzumab govitecan versus treatment of physician's choice in previously treated HR+ and HER2- mBC: a meta-analysis of TROPiCS-02 and EVER-132-002 trials.

Oleg Gluz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.